Subject: A New MOTS-c Study Just Dropped — Here's What It Actually Means
From: Derek from Peptide Price <[email-masked]>
To: [email-masked]
Date: Sun, 5 Apr 2026 01:43:08 +0000
List-Id: <derekpruski.substack.com>

View this post on the web at https://derekpruski.substack.com/p/a-new-mots-c-study-just-dropped-heres

A new peer-reviewed study on MOTS-c was published January 9th out of the University of Copenhagen, and I’ve seen a little chatter about it online — including Coach Cam touching on it on TikTok. I wanted to give my own read on it for the community, broken down in a way that actually makes sense if you’re newer to this stuff. No fluff, just the research.
For research purposes only. Not for human consumption
First — What Is MOTS-c?
MOTS-c is a peptide, but it’s unique because it doesn’t come from your nuclear DNA like most peptides do. It’s encoded directly inside your mitochondria — the structures inside your cells responsible for producing energy (ATP). It’s a 16-amino acid signaling molecule that your body produces naturally, and levels of it rise during exercise and decline with age.
Think of it as a message your mitochondria send to the rest of the cell that says: “we need to run more efficiently.”
What Is This Study?
The full title is “MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner.” Published in Free Radical Biology and Medicine, January 9, 2026. University of Copenhagen researchers ran both mouse experiments and a human exercise trial.
Full study: https://pubmed.ncbi.nlm.nih.gov/41520850/
The Big Question They Were Trying to Answer
Most MOTS-c research up to this point has focused on whole-body metabolic effects — things like insulin sensitivity, glucose uptake, and fat burning. What hasn’t been studied much is what MOTS-c is actually doing inside the mitochondria themselves. That’s what this study went after.
The Main Finding — Efficiency, Not Volume
Here’s the headline: MOTS-c improved mitochondrial bioenergetic performance without any apparent change in mitochondrial respiratory protein content, pointing to intrinsic mitochondrial changes rather than changes in volume.
When researchers talk about improving mitochondrial function, there are basically two ways it can happen:
More mitochondria — your cells build new ones (this is called biogenesis)
Better mitochondria — the ones you already have run more efficiently
A lot of content in the peptide space, including some vendor pages, has described MOTS-c as promoting biogenesis — meaning it helps you grow more mitochondria. This study says that’s not what’s primarily happening. MOTS-c is making your existing mitochondria work better. Same number, higher output. Think of it like tuning an engine rather than adding more cylinders.
How Does It Do That? The Two Pathways
The researchers found that MOTS-c works through two specific proteins — PGC-1α and AMPK — and both had to be present for the effects to show up. That tells us MOTS-c isn’t just nudging one thing, it’s coordinating a system.
AMPK — your cell’s energy sensor
Activates when your cell is running low on energy
Triggers efficiency responses: better glucose uptake, more fat burning, improved mitochondrial function
Exercise activates AMPK — so does MOTS-c, but through a different upstream mechanism (which is why it’s sometimes called an “exercise mimetic”)
PGC-1α — the master regulator of mitochondrial gene expression
When active, it turns on the genes that control how well your mitochondria operate
Think of it as the manager telling the mitochondria how to do their job better
MOTS-c augmented muscle mitochondrial bioenergetic performance through reliance on both PGC-1α and AMPK. Both pathways being required tells us the effect is coordinated, not a simple single-pathway response.
The Oxidative Stress Finding
Mitochondria produce energy, but as a byproduct they also produce reactive oxygen species (ROS) — essentially cellular waste that can damage proteins, DNA, and the mitochondria themselves over time. Too much ROS is one of the key drivers of cellular aging and inflammation.
MOTS-c treatment lowered mitochondrial ROS emission and ROS-related protein damage, indicating substantial alleviation of cellular oxidative stress.
In plain terms:
The mitochondria are running more efficiently
AND producing less cellular waste in the process
That combination is directly relevant to longevity and recovery research
The RNA Data — Why the Improvements Are Spread Out
The researchers also ran RNA sequencing, which lets them see which genes are being turned on or off. What they found is that MOTS-c doesn’t make one big dramatic change. Instead:
The effects appear to be exerted subtly across a number of mitochondrial parameters — including redox handling, mitochondrial integrity, and OXPHOS efficiency — jointly indicating a mechanistic basis for the observed functional improvements.
Breaking those terms down:
Redox handling — how well the cell manages oxidative stress
Mitochondrial integrity — the structural health of the mitochondria themselves
OXPHOS efficiency — how effectively mitochondria convert fuel into usable energy (ATP)
MOTS-c appears to be doing maintenance across all three simultaneously, rather than one dramatic intervention on a single system.
The Human Data Finding — A Nuance Worth Knowing
This is the part that quietly challenges something you’ll still see repeated in a lot of MOTS-c content online.
For years, the assumption has been that skeletal muscle is the main source of MOTS-c circulating in your blood during exercise. This study tested that directly in humans and found: despite increased interstitial MOTS-c levels, no change was observed in the arterio-venous difference during exercise, suggesting that skeletal muscle may not be the source of circulating MOTS-c in response to exercise.
What that means practically:
If skeletal muscle were pumping MOTS-c into the bloodstream during exercise, the arterio-venous difference measurement would have caught it
It didn’t
So where does circulating MOTS-c come from during exercise? Possibly the liver, possibly other tissues — that question is still open
This doesn’t change the benefits observed, it just refines our understanding of the mechanism
The Bottom Line
MOTS-c doesn’t appear to work by building more mitochondria
It makes your existing mitochondria operate with greater efficiency and higher energy output
It simultaneously reduces oxidative stress (ROS) as a byproduct of that improved efficiency
It does this through coordinated activation of both AMPK and PGC-1α — not a single pathway
The improvements are spread across multiple mitochondrial systems at once
For an RS already training and eating well, this study supports MOTS-c research as a “get more out of what you have” tool at the mitochondrial level — not a “build more” tool. The ROS reduction finding adds another layer relevant to anyone researching cellular aging and recovery.
As always — for research purposes only, not for human consumption.
— Derek

Unsubscribe https://substack.com/redirect/2/eyJlIjoiaHR0cHM6Ly9kZXJla3BydXNraS5zdWJzdGFjay5jb20vYWN0aW9uL2Rpc2FibGVfZW1haWw_dG9rZW49ZXlKMWMyVnlYMmxrSWpveU56TTJNakl6T1Rnc0luQnZjM1JmYVdRaU9qRTVNekl5TVRBMk15d2lhV0YwSWpveE56YzFNelV6TXprMExDSmxlSEFpT2pFNE1EWTRPRGt6T1RRc0ltbHpjeUk2SW5CMVlpMHpNelkxTXpZM0lpd2ljM1ZpSWpvaVpHbHpZV0pzWlY5bGJXRnBiQ0o5Lk5LRjlieFo4Q2cybXR5MklUcVZmN1EtRjVNZTVDUkZGX1pfRENTM2VBMmsiLCJwIjoxOTMyMjEwNjMsInMiOjMzNjUzNjcsImYiOnRydWUsInUiOjI3MzYyMjM5OCwiaWF0IjoxNzc1MzUzMzk0LCJleHAiOjIwOTA5MjkzOTQsImlzcyI6InB1Yi0wIiwic3ViIjoibGluay1yZWRpcmVjdCJ9.BBHeo7QydTwrjBLu9GbUCkMXb3D7S9NNed7dmYpINfU?